Amgen

Open: 283.85 Close: 283.51 Change: -0.34

What an AI found about Amgen after reading the whole Internet.

Are looking for the most relevant information about Amgen? Investor spend a lot of time searching for information to make investment decisions in Amgen. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, stock, company, call, Tuesday, market, Amgens, and the most common words in the summary are: amgen, stock, market, inc, top, report, statistic, . One of the sentences in the summary was: Amgen Inc. Other searches related to this term that the AI found were: stockmarketlive, …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

Amgen Inc. stock underperforms t Tuesday when compared to competitors - marketwatch.com.com. Amgen continues its sponsorship of the Irish Open following the acquisition of Horizon Therapeutics plc.

Today's News

Amgen inc. stock underperforms t Tuesday when compared to competitors - marketwatch.com. Amgen Inc. stock outperforms tTuesday when compared with competitors - amgen inc., stock underperforming t Tuesday. Amgen continues its sponsorship of the Irish Open following the acquisition of Horizon Therapeutics plc. The 2024 Amgen Irish Open will take place at the Royal County Down Golf Club in Northern Ireland from Sept. 29. Amgen shares are up more than 30% over the past year, closing at an all-time high of $323 on Friday. At stake is a slice of an obesity market some analysts forecast could reach as much as $150 billion a year. Process Development Senior Associate will be a part of the Process Development Drug Substance Technology group at Amgens FleX Batch Biologics Manufacturing Facility. Amgen offers a Total Rewards Plan comprising health and welfare plans for staff and eligible dependents, financial plans with opportunities to save towards retirement. Amgen sells products primarily to pharmaceutical wholesale distributors in the US. Amgen is headquartered in Thousand Oaks, California. Amgen (NASDAQ:AMGN) stock price for Amgen is $ 283.51 last updated today at 4:48 PM EST. Amgens Q1 earnings are confirmed for Thursday, April 25, 2024. The company is in the Health Care sector and Biotechnology industry. Statistics on Amgen The most important statistics Amgens total revenue 2004-2023. Total worldwide prescription drug revenue - projection 2020-2028 Percentage of global pharmaceutical sales by technology. Top global biotech companies based on number of employees 2023 Sales per employee of select U.S. biotech and drugs companies. Amgen will host a webcasted call at 1pm PT/4pm ET on Thursday to discuss its Rare Disease business. The company has a number of first-in-class medicines on the market. Amgen to host conference call on rare disease. Amgen successfully launched two... amgen to. host conference. call. Webcasted call at 1:00 p.m. February 20, 2024. Amgen stock price is 0.12% down from $283.85 on Tuesday 02/20/2024. Amgen Inc.s market capitalization is $152.59 B by 535.92 M shares outstanding. 69 analysts offering price forecasts for Amgen have a median target of 270.12.

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

The game is changing. There is a new strategy to evaluate Amgen fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, stock, company, call, Tuesday, market, Amgens, and the most common words in the summary are: amgen, stock, market, inc, top, report, statistic, . One of the sentences in the summary was: Amgen Inc. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #stock #market #inc #top #report #statistic.